CTRI News and Funding Opportunities-April2018

Image
UC San Diego Altman Clinical and Translational Research Institute Newsletter:
April 2018, Vol. 3, Issue 4

UC San Diego Altman Clinical and Translational Research Institute (ACTRI) is part of a national Clinical and Translational Science Awards Program (CTSA) consortium, led by the National Institutes of HealthNational Center for Advancing Translational Sciences (NCATS). Established in 2010, ACTRI provides infrastructure and support for basic, translational and clinical research throughout the San Diego region to bring discoveries from the laboratory to the bedside, and facilitates training and education of the next generation of researchers. ACTRI carries out its activities in collaboration with institutional and corporate partners and currently has more than 1,400 members. The ACTRI News and Funding Opportunities is a monthly newsletter.

Director’s Message, Spring 2018

FiresteinI am pleased to announce that Tricorder medical device testing will continue at UC San Diego Altman Clinical and Translational Research Institute (ACTRI). Through a new initiative – the Tricorder Device Development Project – ACTRI and the Jacobs School of Engineering are creating a sustainable testing center for novel consumer and medical devices that can improve health. Medical devices are essential components in advancing medicine and providing critical patient care. Development and testing of new devices, used in the diagnosis and treatment of disease, are integral to ensuring quality of life and patient safety. ACTRI had been the testing site for the Qualcomm Tricorder XPRIZE competition, which concluded last spring. We are excited to lead the new project and test second-generation Star Trek®-inspired medical devices. Read more

Funding Opportunities

NEW**ACTRI and Pfizer Announce the Call for Pre-Proposals for Biotherapeutic and Small-Molecule Targets
Deadline: April 23, 2018

ACTRI Seeks Proposals for Administrative Supplements

ACTRI Vouchers for ACTRI Research Services (In-kind)

NCATS Open Funding Opportunities

Courtesy Postings

ACTRI News and Features

Intriguing Talks Mark ACTRI Translational Science Symposium

Intriguing Talks Mark ACTRI Translational Science Symposium

Former FDA commissioner Robert Califf, MD, and four researchers supported by UC San Diego Altman Clinical and Translational Research Institute (ACTRI) delivered inspiring presentations during the 2018 ACTRI Translational Science Symposium on April 5. The theme of the program was “Emerging Issues and Solutions in Infectious Disease.” More than 100 researchers and staff from UC San Diego and partner institutions attended the symposium, which took place at the ACTRI Building. The event opened with a welcome by ACTRI director Gary S. Firestein, MD, and the presentation of the 2018 Daniel T. O’Connor Memorial Award to Kevin King, MD, PhD, and concluded with the keynote talk by Dr. Califf, “The Role of ‘Real World Evidence’ and Big Data in Development and Assessment of Therapies.” ACTRI executive committee members Colin Depp, PhD, and Paul Mills, PhD, co-led the symposium. The presenters with the ACTRI leaders are (from left): Jeannie Huang, MD, MPH; Paul Mills, PhD; Colin Depp, PhD; Frank Talke, PhD; Gabriel Wagner, MD; Aaron Carlin, MD, PhD; Robert Califf, MD; and Gary S. Firestein, MD. Dr. Califf’s talk will be available on the UC Wellbeing Channel on May 11. Bookmark the UCTV page. Symposium presentation titles.

Daniel T. O’Connor Award Presented to King during ACTRI Symposium

Daniel T. O’Connor Award Presented to King during ACTRI Symposium

Kevin King, MD, PhD, received the 2018 Daniel T. O’Connor Memorial Award during the ACTRI Translational Science Symposium on April 5. Joining hands (from left) are: ACTRI leader Paul Mills, PhD; Kellie Evans-O’Connor; and King. Ms. Evans-O’Connor, the widow of Dr. O’Connor, established the award to provide an additional $5,000 of support each year to the top-ranked ACTRI pilot project. She and Dr. Mills co-presented the award. Read more about Dr. King and his project, “Clinical Pilot of Single Cell Analysis during Human Cardiac Ischemia and Infarction."

Fiza Singh, MDNCATS Features ACTRI-Supported Researcher Fiza Singh, MD, on Website

UC San Diego researcher Fiza Singh, MD, was featured this month on the NCATS Features and Briefs web page. The story, “CTSA Program Support Enables Innovative Study of Brain Function,” is about Dr. Singh’s 2016 ACTRI pilot study on enhancing gamma band response in schizophrenia patients to improve working memory. Read the NCATS story

Trial Innovation Network

Trial Innovation Network

What types of studies should be submitted?
The Trial Innovation Network (TIN) is a platform for multi-center trials and studies that encompass a wide-range of disciplines. Investigators do not need to apply for a specific RFA, but should propose a multi-center trial or study. The Network will prioritize proposals for multi-center clinical trials and studies with patient-oriented endpoints with potential for impact on clinical practice and operational innovation as well as proposals that foster collaborations with other NIH ICs over proposals seeking funding from NCATS. UC San Diego Altman Clinical and Translational Research Institute (ACTRI) is a TIN Hub Liaison Team. Find out more about TIN and consulting with ACTRI on your project.

forward to a friend   ACTRI Facebook   ACTRI Twitter   ACTRI LinkedIn

In This Issue

Upcoming Seminars

ACTRI Seminar Series

Richard H. Scheuermann, PhD

Development and Application of Computational Methods for Analysis of Flow and Mass Cytometry Data: A Chronic Lymphocytic Leukemia Illustration

Thursday, June 7, 2018
2 p.m.

ACTRI Building, First-floor Auditorium

Presented by:
Richard H. Scheuermann, PhD
Director, La Jolla Campus, J. Craig Venter Institute; Adjunct Professor, Department of Pathology, UC San Diego

Read more

ACTRI Communications Seminar for Early Career “K” and Equivalent Awardees

UC San Diego Altman Clinical and Translational Research Institute (ACTRI) is hosting a year-long career development seminar series, “Communicating: Your Academic Life Depends on It,” for early career “K” and equivalent Career Development awardees from UC San Diego, San Diego State University, and ACTRI partner institutions. The ninth session in the series, “HR Issues,” by Janet Kamerman, Chief, Human Resources, UC San Diego Health, and “Project Management, Part 1,” by Joel Dimsdale, MD, is scheduled for Tuesday, May 1. The session will take place at the ACTRI building. RSVP is required to ctri-education@ucsd.edu. Read more

ACTRI Co-Hosts 2018 SoCal Dissemination, Implementation & Improvement Science Symposium

Creating Learning Health and Population Health Systems

Thursday, June 28, 2018
8 a.m. to 4 p.m.

The California Endowment, downtown Los Angeles

Read more, register and learn about submitting poster abstracts

ACTRI-Supported Ethics Forum

Scientists and Society at a Crossroads: Seabed Mining in the Deep Sea

Wednesday, May 2, 2018
5 p.m. to 7 p.m.

Fleet Science Center
Balboa Park, San Diego

Presented by:
Lisa A. Levin, PhD
Distinguished Professor of Biological Oceanography at the Scripps Institution of Oceanography
UC San Diego

Read more

Cite the Grant

citegrantdocDon’t forget to cite the grant!

To help ensure resources are available for future research, please cite the UCSD ACTRI CTSA grant.

Projects and Publications using UCSD ACTRI resources must cite the UCSD ACTRI grant and follow the NIH Public Access Policy.

NIH National Center for Advancing Translational Sciences (NCATS)

CTRI

ACTRI News and Funding Opportunities

Gary S. Firestein, MD
Director of ACTRI

Eric Mah
Chief Administrative Officer

Patricia Wieser
Communications Director

Tracy Dezenzo
Graphic Designer

Follow UC San Diego ACTRI on ACTRI Facebook   ACTRI Twitter   ACTRI LinkedIn

Altman Clinical and Translational Research Institute
9452 Medical Center Drive, La Jolla, CA 92093-0947
Phone: (858) 822-0268
Website: actri.ucsd.edu

Official e-mail of the University of California, San Diego.
Copyright ©2016 Regents of the University of California. All rights reserved.